Prevention of cardiovascular disease: New guidelines, new tools, but challenges remain

Heart

Volumn 100, Issue 9, 2014, Pages 675-677

  Perk, Joep ^a   Graham, Ian ^b   De Backer, Guy ^c  

^a LINNAEUS UNIVERSITY   (Sweden)

^b ADELAIDE AND MEATH HOSPITAL   (Ireland)

^c GHENT UNIVERSITY   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

LOW DENSITY LIPOPROTEIN CHOLESTEROL; TRANS FATTY ACID;

BEHAVIOR CHANGE; CARDIOVASCULAR DISEASE; CARDIOVASCULAR MORTALITY; CARDIOVASCULAR RISK; EDITORIAL; HEALTH PROMOTION; HUMAN; OBESITY; PHYSICAL ACTIVITY; PRACTICE GUIDELINE; PRIORITY JOURNAL; RISK ASSESSMENT; RISK REDUCTION; SMOKING CESSATION; SODIUM RESTRICTION;

CARDIOVASCULAR DISEASES; HUMANS; MORBIDITY; PRACTICE GUIDELINES AS TOPIC; RISK ASSESSMENT; RISK FACTORS; SURVIVAL RATE; WORLD HEALTH;

EID: 84898417543     PISSN: 13556037     EISSN: 1468201X     Source Type: Journal    
DOI: 10.1136/heartjnl-2014-305650     Document Type: Editorial

References (14)

1. JBS3. Joint British Societies' consensus recommendations for the prevention of cardiovascular disease ( JBS3). Heart 2014;100:ii1-ii67.
2. Perk J, De Backer G, Gohlke H, et al. European guidelines on cardiovascular disease prevention in clinical practice (version 2012). The Fifth Joint Task Force of the European Society of Cardiology and Other Societies on Cardiovascular Disease Prevention in Clinical Practice (constituted by representatives of nine societies and by invited experts). Developed with the special contribution of the European Association for Cardiovascular Prevention & Rehabilitation (EACPR). Eur Heart J 2012;33:1635-701.
3. Stone NJ, Robinson J, Lichtenstein AH, et al. 2013 ACC/AHA guideline on the treatment of blood cholesterol to reduce atherosclerotic cardiovascular risk in adults: A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. Circulation 2013. 10.1161/01. cir.0000437738.63853.7a.
4. Eckel RH, Jakicic JM, Ard JD, et al. 2013 AHA/ACC guideline on lifestyle management to reduce cardiovascular risk: A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. Circulation 2013. 10.1161/01.cir.0000437740.48606.d1.
5. Goff DC Jr, Lloyd-Jones DM, Bennett G, et al. 2013 ACC/AHA guideline on the assessment of cardiovascular risk: A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. Circulation 2013. 10.1161/01.cir.0000437741.48606.98.
6. Jensen MD, Ryan DH, Apovian CM, et al. 2013 AHA/ACC/TOS guideline for the management of overweight and obesity in adults: A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and The Obesity Society. Circulation 2013. 10.1161/01. cir.0000437739.71477.ee.
7. Unal B, Critchley JA, Capewell S. Explaining the decline in coronary heart disease mortality in England and Wales between 1981 and 2000. Circulation 2004;109:1101-7. (Pubitemid 38332613)
8. Kotseva K, Wood D, De Backer G, et al. EUROASPIRE III: A survey on the lifestyle, risk factors and use of cardioprotective drug therapies in coronary patients from 22 European countries. Eur J Cardiovasc Prev Rehabil 2009;16:121-37.
9. Banegas JR, Lopez-Garcia E, Dallongeville J, et al. Achievement of treatment goals for primary prevention of cardiovascular disease in clinical practice across Europe: The EURIKA study. Eur Heart J 2011;32:2143-52.
10. Huffman MD, Capewell S, Ning H, et al. Cardiovascular health behavior and health factor changes (1988- 2008) and projections to 2020: results from the National Health and Nutrition Examination Surveys. Circulation 2012;125:2595-602.
11. World Health Organization. Joint WHO/FAO expert consultation on diet, nutrition and the prevention of chronic diseases. Geneva: WHO Technical Report Series, 2002.
12. Ridker PM, Cook NR. Refining the American guidelines for prevention of cardiovascular disease-authors' reply. Lancet 2014;383:600.
13. Graham IM, Cooney MT. Risks in estimating risk. Eur Heart J 2014;35:537-9.
14. Lancet. Statins for millions more? Lancet 2014;383:669.